Stock Track | Arcutis Biotherapeutics Plunges 5.23% in Pre-market Following Q1 Earnings Miss and Insider Selling

Stock Track

05/07

Arcutis Biotherapeutics Inc. (ARQT) experienced a pre-market plunge of 5.23% on Thursday, continuing the negative momentum from the previous trading session.

The sharp decline follows the company's release of its first-quarter 2026 financial results, which revealed a quarterly loss of $0.09 per share. This result missed the analyst consensus estimate of a $0.06 loss by 50 percent, disappointing investors despite the company reporting quarterly sales that exceeded expectations.

Additionally, news of insider selling by the company's Chief Legal Officer, who disposed of 8,256 shares worth approximately $192,893, may have further contributed to negative market sentiment surrounding the stock. The combination of the earnings miss and insider selling appears to have driven the pre-market decline.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1121318769"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121318769\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121318769?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121318769","market":"sg","top_or_hot":-1,"title":"Stock Track | Arcutis Biotherapeutics Plunges 5.23% in Pre-market Following Q1 Earnings Miss and Insider Selling","media":"Stock Track","content":"<p>Arcutis Biotherapeutics Inc. (ARQT) experienced a pre-market plunge of 5.23% on Thursday, continuing the negative momentum from the previous trading session.</p><p>The sharp decline follows the company's release of its first-quarter 2026 financial results, which revealed a quarterly loss of $0.09 per share. This result missed the analyst consensus estimate of a $0.06 loss by 50 percent, disappointing investors despite the company reporting quarterly sales that exceeded expectations.</p><p>Additionally, news of insider selling by the company's Chief Legal Officer, who disposed of 8,256 shares worth approximately $192,893, may have further contributed to negative market sentiment surrounding the stock. The combination of the earnings miss and insider selling appears to have driven the pre-market decline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Arcutis Biotherapeutics Plunges 5.23% in Pre-market Following Q1 Earnings Miss and Insider Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Arcutis Biotherapeutics Plunges 5.23% in Pre-market Following Q1 Earnings Miss and Insider Selling\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-07 19:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Arcutis Biotherapeutics Inc. (ARQT) experienced a pre-market plunge of 5.23% on Thursday, continuing the negative momentum from the previous trading session.</p><p>The sharp decline follows the company's release of its first-quarter 2026 financial results, which revealed a quarterly loss of $0.09 per share. This result missed the analyst consensus estimate of a $0.06 loss by 50 percent, disappointing investors despite the company reporting quarterly sales that exceeded expectations.</p><p>Additionally, news of insider selling by the company's Chief Legal Officer, who disposed of 8,256 shares worth approximately $192,893, may have further contributed to negative market sentiment surrounding the stock. The combination of the earnings miss and insider selling appears to have driven the pre-market decline.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARQT","symbol_name":"Arcutis Biotherapeutics Inc.","start_time":0,"source_url":"","article_id":"1121318769","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121318769","pubTimestamp":1778152602,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Arcutis Biotherapeutics Inc. (ARQT) experienced a pre-market plunge of 5.23% on Thursday, continuing the negative momentum from the previous trading session.The sharp decline follows the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARQT":"Arcutis Biotherapeutics Inc."},"translate_title":"个股追踪|Arcutis Biotherapeutics盘前暴跌5.23%因Q1盈利未达预期和内幕抛售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARQT":1},"content_text":"Arcutis Biotherapeutics Inc. (ARQT) experienced a pre-market plunge of 5.23% on Thursday, continuing the negative momentum from the previous trading session.The sharp decline follows the company's release of its first-quarter 2026 financial results, which revealed a quarterly loss of $0.09 per share. This result missed the analyst consensus estimate of a $0.06 loss by 50 percent, disappointing investors despite the company reporting quarterly sales that exceeded expectations.Additionally, news of insider selling by the company's Chief Legal Officer, who disposed of 8,256 shares worth approximately $192,893, may have further contributed to negative market sentiment surrounding the stock. The combination of the earnings miss and insider selling appears to have driven the pre-market decline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}